Vanda Pharmaceuticals, a publicly traded maker of drugs to treat Non-24-Hour Sleep Wake Disorder and schizophrenia, has hired a health care in-house veteran as its new general counsel.

In addition to serving as GC, Timothy Williams also will be Vanda’s senior vice president and secretary, the Washington, D.C.-based biopharmaceutical company announced Monday. He most recently was executive VP, GC, chief compliance officer and corporate secretary at AgNovos Healthcare, a medical device company focused on bone health.